Literature DB >> 25284229

Female sex protects from organ failure and sepsis after major trauma haemorrhage.

H Trentzsch1, U Nienaber2, M Behnke3, R Lefering4, S Piltz3.   

Abstract

INTRODUCTION: Biological sex is considered a risk factor for adverse outcome after major trauma. We hypothesized that female sex is protective against organ failure, sepsis and mortality in patients with traumatic haemorrhage. PATIENTS AND METHODS: We selected patients from TraumaRegister DGU(®) (TR-DGU) with primary admission for blunt trauma with an injury severity score ≥ 16 and an ICU stay ≥ 3 days that presented with relevant bleeding in the years 2007-2012. Relevant bleeding was defined as Abbreviated Injury Scale (AIS) ≥ 3 with an estimated blood loss exceeding 20%, any femoral shaft fracture, any pelvic clamp as surrogate for unstable pelvic fracture or the presence of at least one criteria of haemorrhagic shock: shock index of 0.8-1.4; base excess of -2.0 to -10.0 mmol/L; body temperature ≤ 34°C; transfusion of ≥ 4 units of packed red blood cells; application of recombinant activated factor VII; any embolization during trauma room phase and pre-hospital resuscitation volume ≥ 3000 ml or any catecholamine use during pre-hospital care in the absence of cardiopulmonary resuscitation. A total of 7560 males and 2774 females were selected and analyzed for sex differences.
RESULTS: Higher rates of multiple organ failure (24.4 vs. 21.3%, Odds ratio [OR] 1.19 (95% confidence interval [95%CI] 1.07-1.33), p=0.001*) and sepsis (16.5 vs. 11.3%, OR 1.55 (95%CI 1.35-1.77), p<0.001*) were observed in males. Organ function of lung, cardio-circulatory system, liver and kidney were better in females, however, there was no difference in mortality. Stratification by age group revealed that in particular age-group 16-44 years was related to improved organ function which may indicate effects of sex hormones in females at reproductive age. Increased rates of sepsis in males were observed throughout virtually all age groups starting at 16 years of age, except in age group 54-64 years. This may suggest suppressive effect of testosterone on immune function.
CONCLUSIONS: Our study supports the hypothesis that female sex is associated with improved organ function following traumatic injury and haemorrhagic shock, in particular in age groups that are at reproductive age. However, further studies are warranted before sex steroids can be deployed as therapeutic intervention in critically ill trauma patients.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Age factors; Blunt trauma; Haemorrhagic shock; Mortality; Multiple trauma; Risk factors; Sex; Sex hormones; Trauma registry

Mesh:

Substances:

Year:  2014        PMID: 25284229     DOI: 10.1016/j.injury.2014.08.013

Source DB:  PubMed          Journal:  Injury        ISSN: 0020-1383            Impact factor:   2.586


  18 in total

1.  Numbers of Severely Injured Patients in Germany. A Retrospective Analysis From the DGU (German Society for Trauma Surgery) Trauma Registry.

Authors:  Florian Debus; Rolf Lefering; Michael Frink; Christian Alexander Kühne; Carsten Mand; Benjamin Bücking; Steffen Ruchholtz
Journal:  Dtsch Arztebl Int       Date:  2015-12-04       Impact factor: 5.594

2.  The PARP inhibitor olaparib exerts beneficial effects in mice subjected to cecal ligature and puncture and in cells subjected to oxidative stress without impairing DNA integrity: A potential opportunity for repurposing a clinically used oncological drug for the experimental therapy of sepsis.

Authors:  Akbar Ahmad; Juliana de Camargo Vieira; Aline Haas de Mello; Thais Martins de Lima; Suely Kubo Ariga; Denise Frediani Barbeiro; Hermes Vieira Barbeiro; Bartosz Szczesny; Gábor Törö; Nadiya Druzhyna; Elisa B Randi; Michela Marcatti; Tracy Toliver-Kinsky; András Kiss; Lucas Liaudet; Reinaldo Salomao; Francisco Garcia Soriano; Csaba Szabo
Journal:  Pharmacol Res       Date:  2019-05-06       Impact factor: 7.658

3.  Risk of bleeding and use of platelet transfusions in patients with hematologic malignancies: recurrent event analysis.

Authors:  Simon J Stanworth; Cara L Hudson; Lise J Estcourt; Rachel J Johnson; Erica M Wood
Journal:  Haematologica       Date:  2015-03-20       Impact factor: 9.941

4.  Risk factors for trauma-induced coagulopathy- and transfusion-associated multiple organ failure in severely injured trauma patients.

Authors:  Kirsten Balvers; Mathijs R Wirtz; Susan van Dieren; J Carel Goslings; Nicole P Juffermans
Journal:  Front Med (Lausanne)       Date:  2015-04-24

5.  Gender differences in outcome and use of resources do exist in Swedish intensive care, but to no advantage for women of premenopausal age.

Authors:  Carolina Samuelsson; Folke Sjöberg; Göran Karlström; Thomas Nolin; Sten M Walther
Journal:  Crit Care       Date:  2015-03-30       Impact factor: 9.097

6.  17β-estradiol suppresses lipopolysaccharide-induced acute lung injury through PI3K/Akt/SGK1 mediated up-regulation of epithelial sodium channel (ENaC) in vivo and in vitro.

Authors:  Di Qi; Jing He; Daoxin Wang; Wang Deng; Yan Zhao; Yuan Ye; Longhua Feng
Journal:  Respir Res       Date:  2014-12-31

7.  What's New in Critical Illness and Injury Science? Estrogen: Is it a new therapeutic paradigm for trauma-hemorrhagic shock?

Authors:  Sanjeev Bhoi; Shreshtha Tiwari; Manoj Kumar
Journal:  Int J Crit Illn Inj Sci       Date:  2016 Apr-Jun

8.  Impact of Sex Differences on Mortality in Patients With Sepsis After Trauma: A Nationwide Cohort Study.

Authors:  Yutaka Kondo; Atsushi Miyazato; Ken Okamoto; Hiroshi Tanaka
Journal:  Front Immunol       Date:  2021-06-29       Impact factor: 7.561

Review 9.  The influence of sex steroid hormones on the response to trauma and burn injury.

Authors:  K Al-Tarrah; N Moiemen; J M Lord
Journal:  Burns Trauma       Date:  2017-09-14

10.  A Retrospective Observational Study Examining the Effect of Thoracic Epidural and Patient Controlled Analgesia on Short-term Outcomes in Blunt Thoracic Trauma Injuries.

Authors:  Edward James Baker; Geraldine Ann Lee
Journal:  Medicine (Baltimore)       Date:  2016-01       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.